Overview
Xenon is a noble gas anesthetic agent used primarily for general anesthesia. It has unique properties including low blood-gas solubility, rapid onset and offset of action, minimal cardiovascular effects, and neuroprotective properties. Xenon is not metabolized in the body and is eliminated unchanged through exhalation.
Mechanism of Action
Xenon acts as an NMDA (N-methyl-D-aspartate) receptor antagonist, inhibiting glutamate-mediated excitatory neurotransmission. It also interacts with other receptors including two-pore domain potassium channels (TREK-1) and acetylcholine receptors, contributing to its anesthetic and analgesic effects.
Indications
- General anesthesia
- Analgesia during surgical procedures
- Neuroprotection in certain clinical situations (investigational)
Dosage
Administered via inhalation: Typically 50-70% Xenon in oxygen mixture for induction and maintenance of anesthesia. Exact dosing determined by anesthesiologist based on patient response and surgical requirements.
Contraindications
- Known hypersensitivity to Xenon
- Pneumothorax or conditions with risk of gas embolism
- Intestinal obstruction with risk of distension
- Patients with closed gas spaces (e.g., middle ear surgery, intraocular gas injection)
Side Effects
- Nausea and vomiting
- Postoperative shivering
- Headache
- Dizziness
- Hypoxia (if improperly administered)
- Cardiac arrhythmias (rare)
- Malignant hyperthermia (theoretical risk)
Interactions
- Potentiates effects of other anesthetic agents
- May interact with neuromuscular blocking agents
- No known significant pharmacokinetic interactions (as not metabolized)